Skip to content
healthcare.dev

PROXEN NP 660

NDC 69729-123, Naproxen Sodium, tablet, from OPMX LLC.

Product NDC
69729-123
Status
Listed
Labeler
OPMX LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA091353
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69729-123 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
69729-123-12697290123121 BLISTER PACK in 1 CARTON (69729-123-12) / 12 TABLET in 1 BLISTER PACK
69729-123-24697290123242 BLISTER PACK in 1 CARTON (69729-123-24) / 12 TABLET in 1 BLISTER PACK
69729-123-506972901235050 POUCH in 1 CARTON (69729-123-50) / 2 TABLET in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 69729-123 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69729-123 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69729-123. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.